<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="in Medicinal Chemistry0065-77431557-8437Elsevier Inc. pmcid: 7233243S0065-7743(20)30014-2 doi: 10.1016/bs.armc.2020.04.001 : Article" exact="Viral" post="G-quadruplexes: New frontiers in virus pathogenesis and antiviral therapy"/>
 <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
 <result pre="powerful evidence for the regulatory role of G4s in key" exact="viral" post="steps. Comprehensive bioinformatics analyses have traced putative G4-forming sequences"/>
 <result pre="rates strongly suggest a crucial role of G4s in the" exact="viral" post="replication cycle and evolution, emphasizing the possibility of targeting"/>
 <result pre="viral replication cycle and evolution, emphasizing the possibility of targeting" exact="viral" post="G4s as a new pharmacological approach in antiviral therapy."/>
 <result pre="G4s in pathogens responsible for serious diseases, such as HIV-1," exact="Hepatitis" post="B and C, Ebola viruses, to cite a few."/>
 <result pre="of the art on the structural and functional characterization of" exact="viral" post="G4s in RNA viruses, DNA viruses and retroviruses. We"/>
 <result pre="present the G4 ligands that provide further details on the" exact="viral" post="G4 role and which, showing promising antiviral activity, which"/>
 <result pre="virus Retrovirus G-quadruplex Antiviral therapy G-quadruplex-ligand Virus life cycle Latency" exact="Chronic" post="infection Non-canonical nucleic acid structure 1 Introduction Viruses, the"/>
 <result pre="Retrovirus G-quadruplex Antiviral therapy G-quadruplex-ligand Virus life cycle Latency Chronic" exact="infection" post="Non-canonical nucleic acid structure 1 Introduction Viruses, the most"/>
 <result pre="with the high mutation and replication rates, has made viruses" exact="plague" post="terrestrial ecosystems since their appearance. Indeed, virus-borne infectious diseases"/>
 <result pre="made viruses plague terrestrial ecosystems since their appearance. Indeed, virus-borne" exact="infectious diseases" post="tend to spread abruptly over wide geographical areas, leading"/>
 <result pre="succeeded in developing new therapeutics for the management of different" exact="viral" post="diseases: for example, anti-retroviral therapy against the human immunodeficiency"/>
 <result pre="different viral diseases: for example, anti-retroviral therapy against the human" exact="immunodeficiency" post="virus (HIV), or the pan-genotypic direct-acting antiviral drugs used"/>
 <result pre="virus (HIV), or the pan-genotypic direct-acting antiviral drugs used for" exact="hepatitis C" post="(HCV) management. Nevertheless, the majority of current therapies are"/>
 <result pre="virus eradication or sustained virological response, therefore the battle against" exact="viral" post="pathogens still represents a primary focus of medical research."/>
 <result pre="response, therefore the battle against viral pathogens still represents a" exact="primary" post="focus of medical research. In addition, the constant onset"/>
 <result pre="of medical research. In addition, the constant onset of new" exact="viral" post="pathogens, generally correlated with massive outbreaks, imperils researchers to"/>
 <result pre="A virus particle, also called a virion, consists of the" exact="viral" post="genome, which can be either DNA or RNA in"/>
 <result pre="protein coat, the capsid. Some virus families additionally present an" exact="external" post="lipid bilayer called envelope, derived from cellular membranes (Fig."/>
 <result pre="genome into the host DNA, or through formation of circular" exact="viral" post="genome molecules (episomes). This process is termed viral latency:"/>
 <result pre="of circular viral genome molecules (episomes). This process is termed" exact="viral" post="latency: through it the virus can evade the host"/>
 <result pre="establishing a lifelong infection.4 It is worth noting that each" exact="viral" post="class has its own peculiar viral cycle: their details"/>
 <result pre="worth noting that each viral class has its own peculiar" exact="viral" post="cycle: their details will be described later in this"/>
 <result pre="cell, according to different mechanisms (step 2). After penetration, the" exact="viral" post="genome is uncoated (step 3) and released into the"/>
 <result pre="cytoplasm, while integration takes place in the cell nucleus. After" exact="viral" post="mRNA synthesis, viral proteins are expressed in the cytoplasm"/>
 <result pre="takes place in the cell nucleus. After viral mRNA synthesis," exact="viral" post="proteins are expressed in the cytoplasm (steps 5â€&quot;6). The"/>
 <result pre="are expressed in the cytoplasm (steps 5â€&quot;6). The newly synthesized" exact="viral" post="elements (genomes and proteins) are assembled into new virions"/>
 <result pre="before transcription AnelloviridaeParvoviridae III dsRNA mRNA transcribed from RNA genome" exact="Reoviridae" post="IV ssRNA (+) RNA genome acts as mRNA CoronaviridaeAstroviridaeCaliciviridaeFaviviridaePicornaviridaeTogaviridae"/>
 <result pre="VII dsDNA â€&quot; RT DNA is transcribed through an RNA" exact="intermediate" post="which acts as mRNA or as template for mRNA"/>
 <result pre="of the relationship between G4s and the regulation of key" exact="viral" post="steps. A recent comprehensive bioinformatics analysis traced putative G4-forming"/>
 <result pre="that characterize viruses, suggesting a crucial role for G4s in" exact="viral" post="evolution and replication, and corroborating their targeting as a"/>
 <result pre="have been reported for most herpesviruses, papillomaviruses and also the" exact="hepatitis" post="B virus (Fig. 3 ). Fig. 3 Summary of"/>
 <result pre="the mRNA; fifth column, G4 ligands tested so far on" exact="viral" post="G4s and corresponding references. 2.1 Herpesviruses The Herpesviridae family"/>
 <result pre="the onset of several different diseases, such as orolabial and" exact="genital herpes," post="chickenpox and shingles, mononucleosis and different types of cancer"/>
 <result pre="genital herpes, chickenpox and shingles, mononucleosis and different types of" exact="cancer" post="(Table 2 ). Interestingly, more than 90% of adults"/>
 <result pre="herpesviruses classification. Table 2 Subfamily Virus Acronym Major related diseases" exact="Alpha" post="Herpes simplex virus type 1 HSV-1 Orolabial herpes, encephalitis"/>
 <result pre="Subfamily Virus Acronym Major related diseases Alpha Herpes simplex virus" exact="type 1" post="HSV-1 Orolabial herpes, encephalitis Herpes simplex virus type 2"/>
 <result pre="diseases Alpha Herpes simplex virus type 1 HSV-1 Orolabial herpes," exact="encephalitis" post="Herpes simplex virus type 2 HSV-2 Genital herpes Varicella"/>
 <result pre="virus type 1 HSV-1 Orolabial herpes, encephalitis Herpes simplex virus" exact="type 2" post="HSV-2 Genital herpes Varicella zoster virus VZV Chickenpox, shingles"/>
 <result pre="Orolabial herpes, encephalitis Herpes simplex virus type 2 HSV-2 Genital" exact="herpes" post="Varicella zoster virus VZV Chickenpox, shingles Beta Cytomegalovirus CMV"/>
 <result pre="encephalitis Herpes simplex virus type 2 HSV-2 Genital herpes Varicella" exact="zoster" post="virus VZV Chickenpox, shingles Beta Cytomegalovirus CMV CMV-mononucleosis, congenital"/>
 <result pre="type 2 HSV-2 Genital herpes Varicella zoster virus VZV Chickenpox," exact="shingles" post="Beta Cytomegalovirus CMV CMV-mononucleosis, congenital cytomegalic inclusion disease Human"/>
 <result pre="Varicella zoster virus VZV Chickenpox, shingles Beta Cytomegalovirus CMV CMV-mononucleosis," exact="congenital" post="cytomegalic inclusion disease Human herpesvirus 6A/6B HHV-6A/B Roseola infantum"/>
 <result pre="VZV Chickenpox, shingles Beta Cytomegalovirus CMV CMV-mononucleosis, congenital cytomegalic inclusion" exact="disease" post="Human herpesvirus 6A/6B HHV-6A/B Roseola infantum Human herpesvirus 7"/>
 <result pre="CMV CMV-mononucleosis, congenital cytomegalic inclusion disease Human herpesvirus 6A/6B HHV-6A/B" exact="Roseola" post="infantum Human herpesvirus 7 HHV-7 Roseola infantum Gamma Epstein-Barr"/>
 <result pre="Human herpesvirus 6A/6B HHV-6A/B Roseola infantum Human herpesvirus 7 HHV-7" exact="Roseola" post="infantum Gamma Epstein-Barr virus EBV Mononucleosis, lymphomas, leukemia, lymphoproliferative"/>
 <result pre="6A/6B HHV-6A/B Roseola infantum Human herpesvirus 7 HHV-7 Roseola infantum" exact="Gamma" post="Epstein-Barr virus EBV Mononucleosis, lymphomas, leukemia, lymphoproliferative syndromes Kaposi's"/>
 <result pre="EBV Mononucleosis, lymphomas, leukemia, lymphoproliferative syndromes Kaposi's sarcoma-associated herpesvirus KSHV" exact="Kaposi's sarcoma," post="Castleman disease HHVs differ significantly in terms of DNA"/>
 <result pre="lymphomas, leukemia, lymphoproliferative syndromes Kaposi's sarcoma-associated herpesvirus KSHV Kaposi's sarcoma," exact="Castleman disease" post="HHVs differ significantly in terms of DNA base composition"/>
 <result pre="leukemia, lymphoproliferative syndromes Kaposi's sarcoma-associated herpesvirus KSHV Kaposi's sarcoma, Castleman" exact="disease" post="HHVs differ significantly in terms of DNA base composition"/>
 <result pre="many biological properties, including the ability to sustain, after a" exact="primary" post="infection, a latent state through maintenance of their genome"/>
 <result pre="of events to achieve replication, which involves both cellular and" exact="viral" post="structures. Briefly, after attachment to the host's cell surface,"/>
 <result pre="cytoplasm and migrates to the nucleus, where it releases the" exact="viral" post="genome. Here, different complex steps lead to the synthesis"/>
 <result pre="complex steps lead to the synthesis of concatemer copies of" exact="viral" post="DNA, which, along with the newly translated viral proteins,"/>
 <result pre="copies of viral DNA, which, along with the newly translated" exact="viral" post="proteins, are assembled into new virions and finally released.11"/>
 <result pre="derivatives. These compounds are classified as nucleosides analogues: they block" exact="viral" post="replication by being incorporated into the nascent viral DNA."/>
 <result pre="they block viral replication by being incorporated into the nascent" exact="viral" post="DNA. They have been widely employed for the treatment"/>
 <result pre="in immunocompromised patients, has led to the onset of resistant" exact="viral" post="strains. Moreover, considering that HHVs undergo latency, and that,"/>
 <result pre="corroborate G4s as functional elements in the regulation of the" exact="viral" post="life cycle.12, 13 In addition, a recent study demonstrated"/>
 <result pre="anti-herpetic therapies. 2.1.1 Alpha-herpesviruses The subfamily of alpha-HHVs includes HSV" exact="type 1" post="and 2, and VZV: these are characterized by the"/>
 <result pre="VZV: these are characterized by the establishment of a persistent" exact="infection" post="in sensory neuronal cells. Most of the studies conducted"/>
 <result pre="characterized by the establishment of a persistent infection in sensory" exact="neuronal" post="cells. Most of the studies conducted on the role"/>
 <result pre="is characterized by 68% GC content, with multiple and highly" exact="stable" post="G4-forming sequences.15 HSV-1 G4s formation has been monitored in"/>
 <result pre="were found to form in a virus cycle-dependent fashion. During" exact="viral" post="replication, viral G4s fold massively in the cell nucleus"/>
 <result pre="to form in a virus cycle-dependent fashion. During viral replication," exact="viral" post="G4s fold massively in the cell nucleus and localize"/>
 <result pre="cell nucleus and localize in different compartments according to the" exact="viral" post="genome movements in the cell during the viral cycle.16"/>
 <result pre="to the viral genome movements in the cell during the" exact="viral" post="cycle.16 Bioinformatics and the following experimental analysis traced conserved"/>
 <result pre="genes that are expressed at the very early stage of" exact="viral infection" post="and encode for regulatory proteins involved in all subsequent"/>
 <result pre="that are expressed at the very early stage of viral" exact="infection" post="and encode for regulatory proteins involved in all subsequent"/>
 <result pre="infection and encode for regulatory proteins involved in all subsequent" exact="viral" post="steps17 (ii) the terminal and internal repeated regions, which"/>
 <result pre="breakpoints.18 Most of the identified G4s proved to be exceptionally" exact="stable" post="when tested in vitro through biochemical and biophysical assays."/>
 <result pre="18Â nM).19 Both compounds led to a significant reduction in" exact="viral" post="DNA synthesis and late transcripts production. Furthermore, in vitro"/>
 <result pre="in a luciferase reporter system that included different PQSs in" exact="viral" post="promoters, NMM was shown to suppress the expression of"/>
 <result pre="of several mRNAs and to reduce both intracellular and extracellular" exact="viral" post="DNA levels.20 Recently, the anti-CMV activity of a polymerase"/>
 <result pre="demonstrated. Interestingly, the compound induced a 2.0 log reduction in" exact="viral" post="titer, together with a significant decrease in the amount"/>
 <result pre="titer, together with a significant decrease in the amount of" exact="viral" post="DNA and pUL44, the viral processivity factor: these data"/>
 <result pre="decrease in the amount of viral DNA and pUL44, the" exact="viral" post="processivity factor: these data indicate that the effect of"/>
 <result pre="indicate that the effect of CX-5461 is exerted at the" exact="viral" post="DNA replication stage of the viral life cycle. Considering"/>
 <result pre="is exerted at the viral DNA replication stage of the" exact="viral" post="life cycle. Considering that the compound is known to"/>
 <result pre="to a double G4-related mechanism of action, involving both the" exact="viral" post="targets and the activation of cellular stress response pathways.21"/>
 <result pre="cause the febrile illness roseola infantum, also called the sixth" exact="childhood" post="eruptive disease. The HHV-6 genome is characterized by the"/>
 <result pre="world, affecting more than 90% of the world's population. Its" exact="primary" post="infection tends to be generally asymptomatic. However it could"/>
 <result pre="affecting more than 90% of the world's population. Its primary" exact="infection" post="tends to be generally asymptomatic. However it could lead"/>
 <result pre="tends to be generally asymptomatic. However it could lead to" exact="infectious" post="mononucleosis and, in the worst case, to various types"/>
 <result pre="EBV nuclear proteins that are expressed only in the latent" exact="infection" post="and sustain the viral episome maintenance.23 Studies on the"/>
 <result pre="are expressed only in the latent infection and sustain the" exact="viral" post="episome maintenance.23 Studies on the characterization and role of"/>
 <result pre="in EBV showed that the EBV-encoded nuclear antigen-1 (EBNA1), the" exact="viral" post="protein pivotal to immune evasion, promotes viral DNA replication"/>
 <result pre="antigen-1 (EBNA1), the viral protein pivotal to immune evasion, promotes" exact="viral" post="DNA replication by interacting with RNA G4s and recruiting"/>
 <result pre="enriched in folded G4s, which behave as cis-acting modulators of" exact="viral" post="mRNA translation, producing ribosome dissociation.24, 25 EBNA1 mRNA G4s"/>
 <result pre="and biochemical characteristics of EBNA1. BRACO-19, for instance, stabilized the" exact="viral" post="RNA G4 and, in infected lymphocytes, reduced EBV genome"/>
 <result pre="show that G4-mediated inhibition affects processes that are crucial for" exact="viral" post="DNA replication,25 reinforcing the importance of alternative DNA structures"/>
 <result pre="been widely shown to bind G4s,27 recognizes and also binds" exact="viral" post="EBNA1 mRNA G4s. As a consequence it downregulates EBNA1"/>
 <result pre="exploited as a pharmacological target to impair both virus and" exact="tumor" post="progression. G4s have also been observed in mRNAs of"/>
 <result pre="2.1.3.2 Kaposi's sarcoma-associated herpesvirus KSHV is the causative agent of" exact="Kaposi's sarcoma" post="and other lymphoproliferative disorders, such as primary effusion lymphoma"/>
 <result pre="Kaposi's sarcoma-associated herpesvirus KSHV is the causative agent of Kaposi's" exact="sarcoma" post="and other lymphoproliferative disorders, such as primary effusion lymphoma"/>
 <result pre="agent of Kaposi's sarcoma and other lymphoproliferative disorders, such as" exact="primary" post="effusion lymphoma and a plasmablastic form of multicentric Castleman's"/>
 <result pre="Kaposi's sarcoma and other lymphoproliferative disorders, such as primary effusion" exact="lymphoma" post="and a plasmablastic form of multicentric Castleman's disease. It"/>
 <result pre="as primary effusion lymphoma and a plasmablastic form of multicentric" exact="Castleman's disease." post="It mostly concerns AIDS patients, as KSHV seroprevalence is"/>
 <result pre="concerns AIDS patients, as KSHV seroprevalence is directly proportional to" exact="HIV seropositivity" post="rates. At the moment, there are no treatments for"/>
 <result pre="arranged in a ~Â 140Â kb long central region, encoding" exact="viral" post="genes, flanked by repeated regions (terminal repeats, or TRs),"/>
 <result pre="by repeated regions (terminal repeats, or TRs), which harbor the" exact="viral" post="episome unique origin of replication. TRs are highly enriched"/>
 <result pre="enriched in G/C bases and have been demonstrated to form" exact="stable" post="G4s, located both in the forward and reverse strands,"/>
 <result pre="and involved in the regulation of episomal replication. Stabilization of" exact="viral" post="G4s by means of different G4 ligands, PhenDC3 and"/>
 <result pre="DNA replication, which resulted in the dramatic reduction (60%) of" exact="viral" post="episome copy numbers.34 In addition, the KSHV latency associated"/>
 <result pre="been also studied in the human papillomavirus (HPV) and the" exact="hepatitis" post="B virus (HBV). 2.2.1 Human papillomavirus HPVs include more"/>
 <result pre="more than 100 characterized viruses, which infect and replicate within" exact="epithelial" post="structures, inducing specific hyperplastic lesions. Among them, those defined"/>
 <result pre="Among them, those defined as â€œhigh-riskâ€� HPVs can efficiently induce" exact="malignant" post="transformation of infected cells, leading to the onset of"/>
 <result pre="of cervical, anogenital, and several oropharyngeal cancers. Notably, high-risk HPVs" exact="infections" post="cause almost 99% of cervical cancers and approximately 5%"/>
 <result pre="the availability of anti-HPV vaccines, access to effective treatments is" exact="limited" post="in many parts of the world; furthermore, no specific"/>
 <result pre="necessary to disclose the involvement of HPV G4s in the" exact="viral" post="life cycle. 2.2.2 Hepatitis B virus HBV is a"/>
 <result pre="involvement of HPV G4s in the viral life cycle. 2.2.2" exact="Hepatitis" post="B virus HBV is a hepatotropic virus, characterized by"/>
 <result pre="an RNA intermediate, synthesized by a reverse transcriptase. Persistent HBV" exact="infections" post="are related to serious liver damage, eventually leading to"/>
 <result pre="infections are related to serious liver damage, eventually leading to" exact="cirrhosis" post="and hepatocellular carcinoma. The pronounced genetic variability associated with"/>
 <result pre="related to serious liver damage, eventually leading to cirrhosis and" exact="hepatocellular carcinoma." post="The pronounced genetic variability associated with HBV determines the"/>
 <result pre="virus loads, response to antiviral therapy, and ability to cause" exact="liver disease." post="Hundreds of millions of people worldwide are chronically infected"/>
 <result pre="BRACO-19 and PDS, revealing a yet unknown role for DNA" exact="secondary" post="structures in the viral context.41 3 RNA viruses RNA"/>
 <result pre="a yet unknown role for DNA secondary structures in the" exact="viral" post="context.41 3 RNA viruses RNA viruses constitute the major"/>
 <result pre="the mRNA; fifth column, G4 ligands tested so far on" exact="viral" post="G4s and corresponding references. 3.1 Flaviviruses The Flaviviridae family"/>
 <result pre="viruses, the genomes of which serve also as mRNA for" exact="viral" post="protein translation. More specifically, the whole genome is translated"/>
 <result pre="unique polyprotein, which subsequently undergoes different cleavages by means of" exact="viral" post="and host proteases, to finally provide three structural proteins,"/>
 <result pre="and seven non-structural (NS) proteins. At both ends of the" exact="viral" post="genome, there are two untranslated regions (UTR) of different"/>
 <result pre="untranslated regions (UTR) of different length, which are essential for" exact="viral" post="replication and immune modulation and whose activity is strongly"/>
 <result pre="immune modulation and whose activity is strongly related to the" exact="secondary" post="structures adopted, mainly stem-loops.43 Flavivirus infections represent a serious"/>
 <result pre="strongly related to the secondary structures adopted, mainly stem-loops.43 Flavivirus" exact="infections" post="represent a serious global threat because of the continuous"/>
 <result pre="flaviviruses are mainly transmitted by mosquitoes or ticks and subsequent" exact="infections" post="can lead to the onset of severe neurological and"/>
 <result pre="including emerging and re-emerging arboviruses of global significance, such as" exact="Japanese encephalitis" post="(JEV), West Nile (WNV), Zika (ZIKV), dengue (DENV), yellow"/>
 <result pre="emerging and re-emerging arboviruses of global significance, such as Japanese" exact="encephalitis" post="(JEV), West Nile (WNV), Zika (ZIKV), dengue (DENV), yellow"/>
 <result pre="Japanese encephalitis (JEV), West Nile (WNV), Zika (ZIKV), dengue (DENV)," exact="yellow fever" post="(YFV), and tick-borne encephalitis (TBEV) virus, and also the"/>
 <result pre="Nile (WNV), Zika (ZIKV), dengue (DENV), yellow fever (YFV), and" exact="tick-borne encephalitis" post="(TBEV) virus, and also the hepatitis C virus (HCV),"/>
 <result pre="(WNV), Zika (ZIKV), dengue (DENV), yellow fever (YFV), and tick-borne" exact="encephalitis" post="(TBEV) virus, and also the hepatitis C virus (HCV),"/>
 <result pre="fever (YFV), and tick-borne encephalitis (TBEV) virus, and also the" exact="hepatitis C" post="virus (HCV), which belongs to the Hepacivirus genus. Albeit"/>
 <result pre="devastating if contracted during pregnancy, as it is related to" exact="microcephaly" post="in the unborn child. Several G4 forming sequences have"/>
 <result pre="within more than 50 analyzed flavivirus genomes. Given the great" exact="viral" post="genome variability, this observation suggests a significant involvement of"/>
 <result pre="region is present in ZIKV: this region is pivotal to" exact="viral" post="replication of the negative-sense strand, therefore it could be"/>
 <result pre="negative-sense strand, therefore it could be a target to impair" exact="viral" post="progression.45 3.1.2 Hepatitis C virus HCV affects more than"/>
 <result pre="it could be a target to impair viral progression.45 3.1.2" exact="Hepatitis" post="C virus HCV affects more than 70 million people"/>
 <result pre="more than 70 million people worldwide. It can cause both" exact="acute" post="and chronic hepatitis, possibly leading to cirrhosis, liver failure"/>
 <result pre="70 million people worldwide. It can cause both acute and" exact="chronic hepatitis," post="possibly leading to cirrhosis, liver failure and cancer. Indeed,"/>
 <result pre="cause both acute and chronic hepatitis, possibly leading to cirrhosis," exact="liver failure" post="and cancer. Indeed, HCV is responsible for 25% of"/>
 <result pre="liver failure and cancer. Indeed, HCV is responsible for 25%" exact="of liver" post="cancers. The HCV genome, in common with that of"/>
 <result pre="demonstrated the existence of six conserved PQSs throughout the whole" exact="viral" post="genome, mostly in the negative strand. The one located"/>
 <result pre="located in the core gene was characterized as the most" exact="stable" post="G4.48 Its stabilization with the G4 ligands TMPyP4 and"/>
 <result pre="the G4 ligands TMPyP4 and a PDS derivative (PDP) promoted" exact="viral" post="RNA-dependent RNA polymerase stalling, with consequent reduction in HCV"/>
 <result pre="compound is in general less selective for G4s.50 Moreover, HCV" exact="infection" post="promoted nucleolin overexpression, which in turn induced a drastic"/>
 <result pre="overexpression, which in turn induced a drastic reduction of HCV" exact="total" post="RNA levels. Conversely, nucleolin silencing was directly correlated with"/>
 <result pre="luciferase system in which luciferase expression was directly related to" exact="viral" post="replication, 60% reduction was observed upon treatment with the"/>
 <result pre="to other G4s in different cell models, probably because during" exact="infections" post="viral G4s outnumber cellular G4s in order to maximize"/>
 <result pre="other G4s in different cell models, probably because during infections" exact="viral" post="G4s outnumber cellular G4s in order to maximize viral"/>
 <result pre="infections viral G4s outnumber cellular G4s in order to maximize" exact="viral" post="replication. Moreover, the HCV replication machinery promotes formation of"/>
 <result pre="replication. Moreover, the HCV replication machinery promotes formation of vesicle-like" exact="viral" post="replication complexes that contain most of the newly synthesized"/>
 <result pre="viral replication complexes that contain most of the newly synthesized" exact="viral" post="RNA, generating a localized G4 enrichment that improves ThT-NE"/>
 <result pre="contain most of the newly synthesized viral RNA, generating a" exact="localized" post="G4 enrichment that improves ThT-NE recognition.52 If this strategy"/>
 <result pre="sequence in the EBOV L gene, which encodes for the" exact="viral" post="RNA-dependent RNA polymerase and modulates viral replication and transcription."/>
 <result pre="which encodes for the viral RNA-dependent RNA polymerase and modulates" exact="viral" post="replication and transcription. In vitro analysis has demonstrated that"/>
 <result pre="the folding into G4s of several sequences derived from original" exact="viral" post="isolates of both EBOV and MARV.54 Additional investigations will"/>
 <result pre="assess the biological role of the identified sequences in the" exact="viral" post="life cycle. 3.3 SARS coronavirus The severe acute respiratory"/>
 <result pre="in the viral life cycle. 3.3 SARS coronavirus The severe" exact="acute" post="respiratory syndrome coronavirus (SARS-CoV) was identified after a massive"/>
 <result pre="the viral life cycle. 3.3 SARS coronavirus The severe acute" exact="respiratory" post="syndrome coronavirus (SARS-CoV) was identified after a massive outbreak"/>
 <result pre="viral life cycle. 3.3 SARS coronavirus The severe acute respiratory" exact="syndrome" post="coronavirus (SARS-CoV) was identified after a massive outbreak in"/>
 <result pre="(+)-ssRNA genome of 29.7Â kb in length, encoding for 13" exact="viral" post="genes. The nonstructural protein 3, also known as SARS"/>
 <result pre="as SARS unique domain (SUD), plays a crucial role in" exact="viral" post="replication and transcription. It was demonstrated to preferentially bind"/>
 <result pre="the modulation of genome replication and host cell response to" exact="viral" post="infection.55, 56 In December 2019, a novel coronavirus named"/>
 <result pre="SARS-CoV2 was identified in Wuhan, China; it causes the coronavirus" exact="disease" post="(COVID-19), which in a minority of people progresses to"/>
 <result pre="(COVID-19), which in a minority of people progresses to severe" exact="atypical pneumonia" post="that requires hospitalization and has extremely high mortality among"/>
 <result pre="which in a minority of people progresses to severe atypical" exact="pneumonia" post="that requires hospitalization and has extremely high mortality among"/>
 <result pre="86% genome homology: they both infect humans by entering the" exact="lower" post="respiratory tract through the angiotensin-converting enzyme 2 (ACE2).58 However,"/>
 <result pre="genome homology: they both infect humans by entering the lower" exact="respiratory" post="tract through the angiotensin-converting enzyme 2 (ACE2).58 However, an"/>
 <result pre="(RT) enzyme, the RNA-dependent DNA polymerase that allows synthesis of" exact="viral" post="DNA from the genomic RNA. The newly formed dsDNA,"/>
 <result pre="LTR located at the 5â€²-end represents the control center for" exact="viral" post="gene expression. It is organized in three sections, U3,"/>
 <result pre="immunological deficiencies, the most known of which is the human" exact="acquired immunodeficiency syndrome" post="(AIDS) caused by HIV-1. Related diseases, associated to different"/>
 <result pre="deficiencies, the most known of which is the human acquired" exact="immunodeficiency" post="syndrome (AIDS) caused by HIV-1. Related diseases, associated to"/>
 <result pre="the most known of which is the human acquired immunodeficiency" exact="syndrome" post="(AIDS) caused by HIV-1. Related diseases, associated to different"/>
 <result pre="all lentiviruses affecting primates showed PQSs in their 5â€²-LTR. A" exact="lower" post="percentage was observed in the bovine lentiviruses, while none,"/>
 <result pre="the key role played by G4s in the regulation of" exact="viral" post="transcription.61 4.1.1 Human immunodeficiency virus type 1 The HIV-1"/>
 <result pre="by G4s in the regulation of viral transcription.61 4.1.1 Human" exact="immunodeficiency" post="virus type 1 The HIV-1 virus, lead representative of"/>
 <result pre="in the regulation of viral transcription.61 4.1.1 Human immunodeficiency virus" exact="type 1" post="The HIV-1 virus, lead representative of the lentivirus subfamily,"/>
 <result pre="or more antiretroviral drugs that reduces virus production and correlated" exact="disease" post="progression (https://www.who.int/gho/hiv/en/, accessed Jan 23, 2020). Nevertheless, there is"/>
 <result pre="in this virus has been quite productive, on both the" exact="viral" post="genomic RNA and the integrated provirus (Fig. 4). The"/>
 <result pre="encapsulated into the new virion: this step is critical for" exact="viral" post="recombination (Fig. 5 ). Several G-rich sequences have been"/>
 <result pre="1) to enter the cell (step 2). After penetration, the" exact="viral" post="genome is uncoated (step 3) and released into the"/>
 <result pre="3) and released into the cytoplasm. At this stage, the" exact="viral" post="RNA is retro-transcribed into a double-stranded intermediate (step 4)"/>
 <result pre="this stage, the viral RNA is retro-transcribed into a double-stranded" exact="intermediate" post="(step 4) which enters the nucleus, where it can"/>
 <result pre="6), mRNA acts as template for the synthesis of new" exact="viral" post="genome copies and for the expression of viral proteins"/>
 <result pre="of new viral genome copies and for the expression of" exact="viral" post="proteins in the cytoplasm (steps 6). The newly synthesized"/>
 <result pre="viral proteins in the cytoplasm (steps 6). The newly synthesized" exact="viral" post="elements (genomes and proteins) are assembled into new virions"/>
 <result pre="point for dimerization between the two RNA strands, contributing to" exact="viral" post="recombination.65 In detail, three G4s have been identified, U3-II,"/>
 <result pre="was able to stall RT progression in vitro, therefore impairing" exact="viral" post="DNA synthesis and thus viral production.66 The nucleocapsid protein"/>
 <result pre="progression in vitro, therefore impairing viral DNA synthesis and thus" exact="viral" post="production.66 The nucleocapsid protein (NCp7), a viral protein that"/>
 <result pre="synthesis and thus viral production.66 The nucleocapsid protein (NCp7), a" exact="viral" post="protein that assists RT by unwinding HIV-1 RNA genome"/>
 <result pre="viral protein that assists RT by unwinding HIV-1 RNA genome" exact="secondary" post="structures in order to promote polymerase progression, could counteract"/>
 <result pre="it promotes folding of nucleic acids in their most thermodynamically" exact="stable" post="conformations.67 It was recently demonstrated that NCp7 contributes to"/>
 <result pre="effects on the LTR promoter activity. LTR-III G4 stabilization inhibits" exact="viral" post="transcription,71 while LTR-IV G4 hampers this activity.73 The folding/unfolding"/>
 <result pre="tested to assess the effect on HIV-1 G4s on the" exact="viral" post="promoter and promising stabilizing activity was observed, leading to"/>
 <result pre="stabilizing activity on HIV-1 LTR G4s, with preference for the" exact="viral" post="over the human telomeric G4s, used as a cellular"/>
 <result pre="three PQSs in the nef gene. This encodes for the" exact="viral" post="accessory protein Nef, a factor involved in the maintenance"/>
 <result pre="Nef, a factor involved in the maintenance of a persistent" exact="HIV infection" post="in vivo. The nef gene is located at the"/>
 <result pre="a factor involved in the maintenance of a persistent HIV" exact="infection" post="in vivo. The nef gene is located at the"/>
 <result pre="The nef gene is located at the 3â€²-end of the" exact="viral" post="genome, with its coding region that partially overlaps with"/>
 <result pre="supports Nef-dependent HIV-1 replication, resulted in a dose-dependent inhibition of" exact="viral" post="infectivity.79 Altogether, these data support the possibility of exploiting"/>
 <result pre="viral infectivity.79 Altogether, these data support the possibility of exploiting" exact="viral" post="G4s as novel anti-HIV-1 targets, possibly in both the"/>
 <result pre="in HIV-1 is their possible involvement in the regulation of" exact="viral" post="latency. The virus establishes a state of latent infection"/>
 <result pre="of viral latency. The virus establishes a state of latent" exact="infection" post="in T cells: at this stage, it is not"/>
 <result pre="G4s to HIV-1 latency. BRACO-19 in latently infected cells reduced" exact="viral" post="titer to undetectable levels, an effect that was still"/>
 <result pre="was still observed after long-term treatment. TMPyP4 administration also blocked" exact="viral" post="replication in two lymphocyte T cell lines with established"/>
 <result pre="ways to harness G4 modulation in other human diseases, including" exact="viral" post="infections. Altogether, the data collected in the past few"/>
 <result pre="ligands and the consequent effect on the modulation of the" exact="viral" post="machinery validate the possibility of developing G4-based antiviral drugs."/>
 <result pre="The first aspect to acknowledge is that all the characterized" exact="viral" post="G4s are located in highly-conserved genomic regions. In virology,"/>
 <result pre="issue, since viruses are characterized by high mutation rates.82 The" exact="limited" post="availability of deposited sequences for many viruses, especially the"/>
 <result pre="design of antiviral G4 ligands is to accomplish selectivity toward" exact="viral" post="versus cellular G4s. As a matter of fact, one"/>
 <result pre="of the G4 structure and are amenable to selective recognition." exact="Structural" post="data on cellular G4/G4 ligand complexes has demonstrated the"/>
 <result pre="loop/groove moieties. To this end, NMR and crystallographic determinations of" exact="viral" post="G4s and their complexes with ligands are necessary, in"/>
 <result pre="hoc design of new antiviral molecules. To date, only two" exact="viral" post="G4 structures have been solved through NMR spectroscopy: the"/>
 <result pre="One possible explanation for this outcome is the amount of" exact="viral" post="G4s, which, during infection, largely exceeds that of cellular"/>
 <result pre="that generally G4s are located in regulatory regions crucial for" exact="viral" post="life cycle progression, a combination of abundance of viral"/>
 <result pre="for viral life cycle progression, a combination of abundance of" exact="viral" post="G4s and impairment of key viral functions might explain"/>
 <result pre="combination of abundance of viral G4s and impairment of key" exact="viral" post="functions might explain the observed antiviral effect. Exploring the"/>
 <result pre="cannot eradicate the latent virus from its host, and consequently" exact="infective" post="agents such as HIV and HHVs still cause non-eradicable"/>
 <result pre="studies reported virus-host chromatin interactions and chromatin machinery modulation by" exact="viral" post="proteins.86 Epigenetic modifications of viral chromatin and viral transcriptome"/>
 <result pre="and chromatin machinery modulation by viral proteins.86 Epigenetic modifications of" exact="viral" post="chromatin and viral transcriptome might be crucial in conveying"/>
 <result pre="modulation by viral proteins.86 Epigenetic modifications of viral chromatin and" exact="viral" post="transcriptome might be crucial in conveying the virus toward"/>
 <result pre="nucleosome-depleted chromatin regions,89 it would be fascinating to understand how" exact="viral" post="G4s affect and could be affected by such a"/>
 <result pre="clarify and further understand the role of G4s in the" exact="viral" post="life cycle and ultimately in viral pathogenesis. G4-mediated antiviral"/>
 <result pre="of G4s in the viral life cycle and ultimately in" exact="viral" post="pathogenesis. G4-mediated antiviral drugs could represent a striking turning"/>
 <result pre="could represent a striking turning point in the management of" exact="viral" post="infectious diseases, especially in people who cannot access immunization,"/>
 <result pre="represent a striking turning point in the management of viral" exact="infectious diseases," post="especially in people who cannot access immunization, such as"/>
 <result pre="Comput. Biol.14122018e100667510.1371/journal.pcbi.1006675 7PayneS.Introduction to DNA VirusesViruses2017Elsevier23123610.1016/b978-0-12-803109-4.00028-3 8LiebermanP.M.Epigenetics and Genetics of" exact="Viral" post="LatencyCell Host Microbe195201661962810.1016/j.chom.2016.04.00827173930 9LanK.LuoM.H.Herpesviruses: Epidemiology, Pathogenesis, and InterventionsVirol. Sin.325201734734810.1007/s12250-017-4108-229116595"/>
 <result pre="Viruses and Their HostsMolecules24102019194210.3390/molecules24101942 15ArtusiS.NadaiM.PerroneR.BiasoloM.A.PaluG.FlamandL.CalistriA.RichterS.N.The Herpes Simplex Virus-1 Genome Contains" exact="Multiple" post="Clusters of Repeated G-Quadruplex: Implications for the Antiviral Activity"/>
 <result pre="CytomegalovirusPLoS Pathog.1492018e100733410.1371/journal.ppat.1007334 21WestdorpK.N.TerhuneS.S.Impact of RNA Polymerase I Inhibitor CX-5461 on" exact="Viral" post="Kinase-Dependent and -Independent Cytomegalovirus ReplicationAntiviral Res.1532018333810.1016/j.antiviral.2018.02.01429458130 22Gilbert-GirardS.GravelA.ArtusiS.RichterS.N.WallaschekN.KauferB.B.FlamandL.Stabilization of Telomere"/>
 <result pre="Epstein-Barr Virus-Encoded Nuclear Antigen 1 MRNA TranslationNat. Chem. Biol.105201435836410.1038/nchembio.147924633353 26TellamJ.T.ZhongJ.LekieffreL.BhatP.MartinezM.CroftN.P.KaplanW.TellamR.L.KhannaR.MRNA" exact="Structural" post="Constraints on EBNA1 Synthesis Impact on in Vivo Antigen"/>
 <result pre="Antigenic PeptidesNucleic Acids Res.47620193086310010.1093/nar/gky129630624716 32El-SharkawyA.Al ZaidanL.MalkiA.Epstein-Barr Virus-Associated Malignancies: Roles of" exact="Viral" post="Oncoproteins in CarcinogenesisFront. Oncol.8201826510.3389/fonc.2018.0026530116721 33GoncalvesP.H.ZiegelbauerJ.UldrickT.S.YarchoanR.Kaposi Sarcoma Herpesvirus-Associated Cancers and"/>
 <result pre="Virus-Associated Malignancies: Roles of Viral Oncoproteins in CarcinogenesisFront. Oncol.8201826510.3389/fonc.2018.0026530116721 33GoncalvesP.H.ZiegelbauerJ.UldrickT.S.YarchoanR.Kaposi" exact="Sarcoma" post="Herpesvirus-Associated Cancers and Related DiseasesCurr. Opin. HIV AIDS1212017475610.1097/coh.000000000000033027662501 34MadireddyA.PurushothamanP.LoosbroockC.P.RobertsonE.S.SchildkrautC.L.VermaS.C.G-Quadruplex-Interacting"/>
 <result pre="LANA MRNA Through G-QuadruplexesJ. Virol.9432020015080151910.1128/JVI.01508-19 36DoorbarJ.EgawaN.GriffinH.KranjecC.MurakamiI.Human Papillomavirus Molecular Biology and" exact="Disease" post="AssociationRev. Med. Virol.25201522310.1002/rmv.182225752814 37TluckovaK.MarusicM.TothovaP.BauerL.SketP.PlavecJ.ViglaskyV.Human Papillomavirus G-QuadruplexesBiochemistry524120137207721610.1021/bi400897g24044463 38MarusicM.HosnjakL.KrafcikovaP.PoljakM.ViglaskyV.PlavecJ.The Effect of"/>
 <result pre="Nucleotide Polymorphisms in G-Rich Regions of High-Risk Human Papillomaviruses on" exact="Structural" post="Diversity of DNABiochim. Biophys. Acta18615 Pt. B20171229123610.1016/j.bbagen.2016.11.007 39MaruÅ¡iÄ�M.PlavecJ.Towards Understanding"/>
 <result pre="G-Rich Region of Human Papillomavirus Type 52Molecules2472019129410.3390/molecules24071294 40ZoulimF.LebossÃ©F.LevreroM.Current Treatments for" exact="Chronic" post="Hepatitis B Virus InfectionsCurr. Opin. Virol.18201610911610.1016/j.coviro.2016.06.00427318098 41BiswasB.KandpalM.VivekanandanP.A G-Quadruplex Motif"/>
 <result pre="Region of Human Papillomavirus Type 52Molecules2472019129410.3390/molecules24071294 40ZoulimF.LebossÃ©F.LevreroM.Current Treatments for Chronic" exact="Hepatitis" post="B Virus InfectionsCurr. Opin. Virol.18201610911610.1016/j.coviro.2016.06.00427318098 41BiswasB.KandpalM.VivekanandanP.A G-Quadruplex Motif in"/>
 <result pre="the Global RNA ViromeMBio962018e02329-1810.1128/mBio.02329-18 43ChongH.Y.LeowC.Y.Abdul MajeedA.B.LeowC.H.Flavivirus Infectionâ€&quot;A Review of Immunopathogenesis," exact="Immunological" post="Response, and ImmunodiagnosisVirus Res.274201919777010.1016/j.virusres.2019.19777031626874 44BaharuddinA.HassanA.ShengG.NasirS.OthmanS.YusofR.OthmanR.RahmanN.Current Approaches in Antiviral Drug"/>
 <result pre="G-Quadruplexes Characteristic of the Flaviviridae FamilyACS Infect. Dis.210201667468110.1021/acsinfecdis.6b0010927737553 46GawlikK.GallayP.A.HCV Core" exact="Protein" post="and Virus Assembly: What We Know Without StructuresImmunol. Res.601201411010.1007/s12026-014-8494-324557493"/>
 <result pre="behindInt. J. Antimicrob. Agents536201975576010.1016/j.ijantimicag.2018.12.01030605721 48BianW.-X.XieY.WangX.-N.XuG.-H.FuB.-S.LiS.LongG.ZhouX.ZhangX.-L.Binding of Cellular Nucleolin With the" exact="Viral" post="Core RNA G-Quadruplex Structure Suppresses HCV ReplicationNucleic Acids Res.4712019566810.1093/nar/gky117730462330"/>
 <result pre="ReplicationNucleic Acids Res.4712019566810.1093/nar/gky117730462330 49WangS.R.MinY.Q.WangJ.Q.LiuC.X.FuB.S.WuF.WuL.Y.QiaoZ.X.SongY.Y.XuG.H.A Highly Conserved G-Rich Consensus Sequence in" exact="Hepatitis" post="C Virus Core Gene Represents a New Anti-Hepatitis C"/>
 <result pre="Gene Represents a New Anti-Hepatitis C TargetSci. Adv.242016e150153510.1126/sciadv.1501535 50RenJ.ChairesJ.B.Sequence and" exact="Structural" post="Selectivity of Nucleic Acid Binding LigandsBiochemistry38491999160671607510.1021/bi992070s10587429 51JaubertC.BedratA.BartolucciL.Di PrimoC.VenturaM.MergnyJ.L.AmraneS.AndreolaM.L.RNA Synthesis"/>
 <result pre="LigandsBiochemistry38491999160671607510.1021/bi992070s10587429 51JaubertC.BedratA.BartolucciL.Di PrimoC.VenturaM.MergnyJ.L.AmraneS.AndreolaM.L.RNA Synthesis Is Modulated by G-Quadruplex Formation in" exact="Hepatitis" post="C Virus Negative RNA StrandSci. Rep.812018812010.1038/s41598-018-26582-329802381 52LuoX.XueB.FengG.ZhangJ.LinB.ZengP.LiH.YiH.ZhangX.-L.ZhuH.Lighting up the"/>
 <result pre="C Virus Negative RNA StrandSci. Rep.812018812010.1038/s41598-018-26582-329802381 52LuoX.XueB.FengG.ZhangJ.LinB.ZengP.LiH.YiH.ZhangX.-L.ZhuH.Lighting up the Native" exact="Viral" post="RNA Genome With a Fluorogenic Probe for the Live-Cell"/>
 <result pre="G-QuadruplexesPLoS Pathog.552009e100042810.1371/journal.ppat.1000428 56KusovY.TanJ.AlvarezE.EnjuanesL.HilgenfeldR.A G-Quadruplex-Binding Macrodomain Within the â€œSARS-Unique Domainâ€� Is" exact="Essential" post="for the Activity of the SARS-Coronavirus Replication-Transcription ComplexVirology484201531332210.1016/j.virol.2015.06.01626149721 57WeissP.MurdochD.R.Clinical"/>
 <result pre="the SARS-Coronavirus Replication-Transcription ComplexVirology484201531332210.1016/j.virol.2015.06.01626149721 57WeissP.MurdochD.R.Clinical Course and Mortality Risk of" exact="Severe" post="COVID-19Lancet39520201014101532197108 58Wilder-SmithA.ChiewC.J.LeeV.J.Can We Contain the COVID-19 Outbreak With the"/>
 <result pre="Same Measures as for SARS?Lancet. Infect. Dis.2020 59FungS.-Y.YuenK.-S.YeZ.-W.ChanC.-P.JinD.-Y.A Tug-of-War Between" exact="Severe" post="Acute Respiratory Syndrome Coronavirus 2 and Host Antiviral Defence:"/>
 <result pre="Measures as for SARS?Lancet. Infect. Dis.2020 59FungS.-Y.YuenK.-S.YeZ.-W.ChanC.-P.JinD.-Y.A Tug-of-War Between Severe" exact="Acute" post="Respiratory Syndrome Coronavirus 2 and Host Antiviral Defence: Lessons"/>
 <result pre="as for SARS?Lancet. Infect. Dis.2020 59FungS.-Y.YuenK.-S.YeZ.-W.ChanC.-P.JinD.-Y.A Tug-of-War Between Severe Acute" exact="Respiratory" post="Syndrome Coronavirus 2 and Host Antiviral Defence: Lessons From"/>
 <result pre="for SARS?Lancet. Infect. Dis.2020 59FungS.-Y.YuenK.-S.YeZ.-W.ChanC.-P.JinD.-Y.A Tug-of-War Between Severe Acute Respiratory" exact="Syndrome" post="Coronavirus 2 and Host Antiviral Defence: Lessons From Other"/>
 <result pre="63SundquistW.I.HeaphyS.Evidence for Interstrand Quadruplex Formation in the Dimerization of Human" exact="Immunodeficiency" post="Virus 1 Genomic RNAProc. Natl. Acad. Sci. U. S."/>
 <result pre="U. S. A.9081993339333978475087 64Piekna-PrzybylskaD.SharmaG.BambaraR.A.Mechanism of HIV-1 RNA Dimerization in the" exact="Central" post="Region of the Genome and Significance for Viral EvolutionJ."/>
 <result pre="in the Central Region of the Genome and Significance for" exact="Viral" post="EvolutionJ. Biol. Chem.288332013241402415010.1074/jbc.M113.47726523839990 65Piekna-PrzybylskaD.SullivanM.A.SharmaG.BambaraR.A.U3 Region in the HIV-1 Genome"/>
 <result pre="Tetramolecular Antiparallel G-Quadruplex FormationJ. Am. Chem. Soc.135492013185751858510.1021/ja409085j24224650 68ButovskayaE.SoldÃ P.ScalabrinM.NadaiM.RichterS.N.HIV-1 Nucleocapsid" exact="Protein" post="Unfolds Stable RNA G-Quadruplexes in the Viral Genome and"/>
 <result pre="G-Quadruplex FormationJ. Am. Chem. Soc.135492013185751858510.1021/ja409085j24224650 68ButovskayaE.SoldÃ P.ScalabrinM.NadaiM.RichterS.N.HIV-1 Nucleocapsid Protein Unfolds" exact="Stable" post="RNA G-Quadruplexes in the Viral Genome and Is Inhibited"/>
 <result pre="68ButovskayaE.SoldÃ P.ScalabrinM.NadaiM.RichterS.N.HIV-1 Nucleocapsid Protein Unfolds Stable RNA G-Quadruplexes in the" exact="Viral" post="Genome and Is Inhibited by G-Quadruplex LigandsACS Infect. Dis.51220192127213510.1021/acsinfecdis.9b0027231646863"/>
 <result pre="LigandsACS Infect. Dis.51220192127213510.1021/acsinfecdis.9b0027231646863 69LyonnaisS.GorelickR.J.MergnyJ.-L.Le CamE.MirambeauG.G-Quartets Direct Assembly of HIV-1 Nucleocapsid" exact="Protein" post="along Single-Stranded DNANucleic Acids Res.311920035754576310.1093/nar/gkg71614500839 70AmraneS.KerkourA.BedratA.VialetB.AndreolaM.L.MergnyJ.L.Topology of a DNA"/>
 <result pre="G-Quadruplex Structures Folded by the LTR Promoter and Silences HIV-1" exact="Viral" post="TranscriptionNucleic Acids Res.431820158884889710.1093/nar/gkv89726354862 75ScalabrinM.FrassonI.RuggieroE.PerroneR.TosoniE.LagoS.TassinariM.PalÃ¹G.RichterS.N.The Cellular Protein HnRNP A2/B1 Enhances"/>
 <result pre="Promoter and Silences HIV-1 Viral TranscriptionNucleic Acids Res.431820158884889710.1093/nar/gkv89726354862 75ScalabrinM.FrassonI.RuggieroE.PerroneR.TosoniE.LagoS.TassinariM.PalÃ¹G.RichterS.N.The Cellular" exact="Protein" post="HnRNP A2/B1 Enhances HIV-1 Transcription by Unfolding LTR Promoter"/>
 <result pre="Long Terminal Repeat Promoter of the HIV-1 Proviral Genome Modulates" exact="Viral" post="TranscriptionNucleic Acids Res.47212019110571106810.1093/nar/gkz93731665504 78PerroneR.DoriaF.ButovskayaE.FrassonI.BottiS.ScalabrinM.LagoS.GrandeV.NadaiM.FrecceroM.Synthesis, Binding and Antiviral Properties of"/>
 <result pre="Characteristic of Cells Infected With Latent HIV-1Cell Cycle1610201796897810.1080/15384101.2017.131222528388353 82PeckK.M.LauringA.S.Complexities of" exact="Viral" post="Mutation RatesJ. Virol.92142018e01031-1710.1128/jvi.01031-17 83SpiegelJ.AdhikariS.BalasubramanianS.The Structure and Function of DNA"/>
 <result pre="by an Acridine DrugJ. Am. Chem. Soc.1302120086722672410.1021/ja801697318457389 85NadaiM.DoriaF.ScalabrinM.PirotaV.GrandeV.BergamaschiG.AmendolaV.WinnerdyF.R.PhanA.T.RichterS.N.A Catalytic and" exact="Selective" post="Scissoring Molecular Tool for Quadruplex Nucleic AcidsJ. Am. Chem."/>
 <result pre="Quadruplex Nucleic AcidsJ. Am. Chem. Soc.140442018145281453210.1021/jacs.8b0533730351011 86KnipeD.M.LiebermanP.M.JungJ.U.McBrideA.A.MorrisK.V.OttM.MargolisD.NietoA.NevelsM.ParksR.J.Snapshots: Chromatin Control of" exact="Viral" post="InfectionVirology4351201314115610.1016/j.virol.2012.09.02323217624 87KnipeD.M.CliffeA.Chromatin Control of Herpes Simplex Virus Lytic and"/>
 <result pre="Microbiol.63200821122110.1038/nrmicro179418264117 88FlemingA.M.NguyenN.L.B.BurrowsC.J.Colocalization of m 6 A and G-Quadruplex-Forming Sequences in" exact="Viral" post="RNA (HIV, Zika, Hepatitis B, and SV40) Suggests Topological"/>
 <result pre="6 A and G-Quadruplex-Forming Sequences in Viral RNA (HIV, Zika," exact="Hepatitis" post="B, and SV40) Suggests Topological Control of Adenosine N"/>
</results>
